Order Detail

Order In the Matter of Second Phase review acquisition of the Global Vaccines business (excluding influenza vaccines business except in China) from Novartis A.G by Glaxosmithkline PLC
brief description
Section 11
Violation: Second Phase Review (favorable order with condition)
Sector: Pharmaceutical
Penalty: No Penalty
Adjudicating Members
Members: Ms. Vadiyya Khalil Dr. Joseph Wilson Dr. Shahzad Ansar Mr. Mueen Batlay Mr. Ikram UI Haque Qureshi

DISCLAIMER

This order summary is intended to provide a brief overview of the Competition Commission of Pakistan's (CCP) order and should not be considered a substitute for the original order. Undertakings and stakeholders are strongly advised to download the full order to obtain a comprehensive understanding of its contents. No warranty expressed or implied is made regarding adequacy or completeness of any information. This disclaimer applies to both isolated and aggregate use of information.

© CCP 2024, Competition Commission of Pakistan ©All rights reserved